Myelitis, Transverse
Recent clinical, regulatory, research and industry developments relating to this disease.
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
- 1 clinical trial expected to report results, the earliest in Q2 2029.
Clinical MilestonesViewHide
Clinical trials
The current development programme across all trial phases.
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Leading journals1
- Journal of neurology, neurosurgery, and psychiatry1
Leading researchers8
- Barnett MH1
- Brilot F1
- Broadley S1
- Dale RC1
- Fung VSC1
- Henderson APD1
- Lechner-Scott J1
- Merheb V1
Affiliations (unnormalised)6
- Brain and Mind Centre1
- Children's Hospital1
- Department of Clinical Medicine1
- Gold Coast University Hospital1
- Hunter Medical Research Institute1
- Institute for Neuroscience and Muscle Research1
Reference
Authoritative identity, definition & identifiers.
Inflammation of a transverse portion of the spinal cord characterized by acute or subacute segmental demyelination or necrosis. The condition may occur sporadically, follow an infection or vaccination, or present as a paraneoplastic syndrome (see also ENCEPHALOMYELITIS, ACUTE DISSEMINATED). Clinical manifestations include motor weakness, sensory loss, and incontinence. (Adams et al., Principles of Neurology, 6th ed, pp1242-6)
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.